Clin2
NCT07532538Likely a fitNot yet recruiting

Machine learning tool to predict head and neck cancer risk

Hypopharyngeal CancerLaryngeal CancerHead and Neck Cancer

Part of Cancer, Ear, nose & throat, Lungs & breathing, Mouth & dental clinical trials.

This study tests a computer program designed to help doctors predict which head and neck lesions (abnormal tissue growths) might be cancerous. Researchers will use your medical information and throat imaging to teach the program, which could help catch cancer earlier.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
18 years to 100 years
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You have complete medical records and information available
  • You have laryngoscopic images (pictures taken during a throat examination with a camera)
  • You are willing to sign a consent form allowing your data to be used in the study
  • You do not have a diagnosis of other head and neck cancers (such as thyroid cancer or salivary gland tumors)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07190573Recruiting
Precision medicine study for head and neck cancer

This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.

Seoul, Seoul
NCT05097625Recruiting
Testing early detection of head and neck cancer relapse

This study aims to find signs of head and neck cancer coming back early, using scans/tests after you’ve had radical treatment. If you’re at higher risk and HPV-negative, this may help doctors catch relapse sooner.

London
NCT06809673Enrolling by invitation
Blood markers in head and neck cancer surgery

This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.

Genoa
NCT05375266Recruiting
Study of immune signals in head and neck cancer

This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.

Erlangen, Bavaria
NCT04261192Recruiting
Grow lab models of head and neck cancer to test treatments

This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.

Caen
NCT05894070Recruiting
Using your voice recordings to spot cancer coming back

This study looks at whether changes in your voice can help detect early return of laryngeal or hypopharyngeal cancer. If you’ve finished curative treatment and are disease-free for a certain period, your voice will be monitored to see if it can signal recurrence sooner.

Bern

Hear when a new Hypopharyngeal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.